Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Rivaroxaban
Warfarin
Locations
1
United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Start Date
October 10, 2020
Primary Completion Date
June 11, 2021
Completion Date
June 11, 2021
Last Updated
July 28, 2023
NCT06183944
NCT06189313
NCT06357403
NCT06451003
NCT06480994
NCT06954727
Lead Sponsor
Brigham and Women's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions